Geneva Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21,540	Closed	-$674K	–	788
2017 Q1	$674K	Buy	21,540 +11,726	+119%	+$367K	0.01%	432
2016 Q4	$248K	Buy	+9,814	New	+$248K	﹤0.01%	630